NZ548367A - Non-nucleoside reverse transcriptase inhibitors - Google Patents

Non-nucleoside reverse transcriptase inhibitors

Info

Publication number
NZ548367A
NZ548367A NZ548367A NZ54836704A NZ548367A NZ 548367 A NZ548367 A NZ 548367A NZ 548367 A NZ548367 A NZ 548367A NZ 54836704 A NZ54836704 A NZ 54836704A NZ 548367 A NZ548367 A NZ 548367A
Authority
NZ
New Zealand
Prior art keywords
mmol
difluoro
tetrahydro
cyclopropa
fluoro
Prior art date
Application number
NZ548367A
Other languages
English (en)
Inventor
Christian Sund
Nathalie Roue
Stefan Lindstrom
Dmitry Antonov
Christer Sahlberg
Katarina Jansson
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400021A external-priority patent/SE0400021D0/xx
Priority claimed from SE0400585A external-priority patent/SE0400585D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of NZ548367A publication Critical patent/NZ548367A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ548367A 2004-01-08 2004-12-30 Non-nucleoside reverse transcriptase inhibitors NZ548367A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0400021A SE0400021D0 (sv) 2004-01-08 2004-01-08 Non-nucleoside reverse transcriptase inhibitors
SE0400585A SE0400585D0 (sv) 2004-03-09 2004-03-09 NNRTI Antivirals
PCT/SE2004/002034 WO2005066131A1 (en) 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
NZ548367A true NZ548367A (en) 2010-06-25

Family

ID=34752289

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ548367A NZ548367A (en) 2004-01-08 2004-12-30 Non-nucleoside reverse transcriptase inhibitors

Country Status (15)

Country Link
US (1) US7915295B2 (OSRAM)
EP (1) EP1701942B1 (OSRAM)
JP (1) JP4762917B2 (OSRAM)
AT (1) ATE451357T1 (OSRAM)
AU (1) AU2004312284B2 (OSRAM)
BR (1) BRPI0418306B8 (OSRAM)
CA (1) CA2550187C (OSRAM)
DE (1) DE602004024584D1 (OSRAM)
DK (1) DK1701942T3 (OSRAM)
EA (1) EA009700B1 (OSRAM)
ES (1) ES2337794T3 (OSRAM)
IL (1) IL176740A (OSRAM)
NZ (1) NZ548367A (OSRAM)
SG (1) SG149070A1 (OSRAM)
WO (1) WO2005066131A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05002545A (es) * 2002-09-05 2005-09-30 Medivir Ab Inhibidores de transcriptasa inversa sin nucleosidos.
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
ES2539527T3 (es) * 2005-04-27 2015-07-01 Taimed Biologics, Inc. Método para mejorar la farmacocinética de los inhibidores de las proteasas y de los precursores de los inhibidores de las proteasas
JP2009517412A (ja) 2005-11-30 2009-04-30 アンブリリア バイオファーマ インコーポレイテッド アスパルチルプロテアーゼ阻害物質のリジンベースのプロドラッグ及びその調製方法
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
WO2007136572A2 (en) * 2006-05-15 2007-11-29 Merck & Co., Inc. Antidiabetic bicyclic compounds
US8410300B2 (en) 2006-09-21 2013-04-02 Taimed Biologics, Inc. Protease inhibitors
JP6636031B2 (ja) * 2015-01-30 2020-01-29 ジェネンテック, インコーポレイテッド 治療用化合物およびその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003327B1 (ru) * 1998-01-16 2003-04-24 Медивир Аб Антивирусные соединения
WO1999051613A1 (en) * 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) * 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
MXPA05002545A (es) * 2002-09-05 2005-09-30 Medivir Ab Inhibidores de transcriptasa inversa sin nucleosidos.

Also Published As

Publication number Publication date
JP4762917B2 (ja) 2011-08-31
US20080070951A1 (en) 2008-03-20
CA2550187A1 (en) 2005-07-21
ES2337794T3 (es) 2010-04-29
HK1101400A1 (en) 2007-10-18
IL176740A (en) 2011-09-27
BRPI0418306B1 (pt) 2018-09-18
DK1701942T3 (da) 2010-04-06
ATE451357T1 (de) 2009-12-15
IL176740A0 (en) 2006-10-31
EA200601289A1 (ru) 2006-12-29
EP1701942A1 (en) 2006-09-20
DE602004024584D1 (de) 2010-01-21
EP1701942B1 (en) 2009-12-09
AU2004312284A2 (en) 2005-07-21
EA009700B1 (ru) 2008-02-28
BRPI0418306B8 (pt) 2021-05-25
CA2550187C (en) 2012-08-07
BRPI0418306A (pt) 2007-05-02
WO2005066131A1 (en) 2005-07-21
SG149070A1 (en) 2009-01-29
US7915295B2 (en) 2011-03-29
JP2007519640A (ja) 2007-07-19
AU2004312284A1 (en) 2005-07-21
AU2004312284B2 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
CA2550187C (en) Non-nucleoside reverse transcriptase inhibitors
CA2438524C (en) Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
AU2003260492B2 (en) Non-nucleoside reverse transcriptase inhibitors
AU2002308231A1 (en) Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
US6610714B2 (en) Non-nucleoside reverse transcriptase inhibitors
CN1926108B (zh) 非核苷酸逆转录酶抑制剂
MXPA06007726A (en) Non-nucleotide reverse transcriptase inhibitors
HK1101400B (en) Non-nucleotide reverse transcriptase inhibitors
AU2002311031A1 (en) Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 DEC 2015 BY LEA

Effective date: 20141211

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 DEC 2016 BY LEA SKYLLERSTEDT

Effective date: 20151210

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 DEC 2017 BY CPA GLOBAL (PATRAFEE)

Effective date: 20161208

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 DEC 2018 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20171130

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 DEC 2019 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20181217

LAPS Patent lapsed